BlackRock’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-870,271
| Closed | -$505K | – | 5505 |
|
|
2024
Q3 | $505K | Sell |
870,271
-1,724
| -0.2% | -$966 | ﹤0.01% | 4325 |
|
|
2024
Q2 | $539K | Sell |
871,995
-4,917,673
| -85% | -$4.15M | ﹤0.01% | 4328 |
|
|
2024
Q1 | $14.9M | Sell |
5,789,668
-78,685
| -1% | -$192K | ﹤0.01% | 3149 |
|
|
2023
Q4 | $12M | Sell |
5,868,353
-219,696
| -4% | -$401K | ﹤0.01% | 3301 |
|
|
2023
Q3 | $10.5M | Sell |
6,088,049
-125,383
| -2% | -$223K | ﹤0.01% | 3301 |
|
|
2023
Q2 | $12.1M | Buy |
6,213,432
+4,280,777
| +221% | +$10M | ﹤0.01% | 3323 |
|
|
2023
Q1 | $5.37M | Sell |
1,932,655
-21,879
| -1% | -$62.5K | ﹤0.01% | 3604 |
|
|
2022
Q4 | $6.74M | Buy |
1,954,534
+28,582
| +1% | +$81.6K | ﹤0.01% | 3576 |
|
|
2022
Q3 | $4.95M | Buy |
1,925,952
+12,081
| +0.6% | +$38.5K | ﹤0.01% | 3760 |
|
|
2022
Q2 | $4.63M | Sell |
1,913,871
-1,979,522
| -51% | -$5.2M | ﹤0.01% | 3853 |
|
|
2022
Q1 | $16M | Buy |
3,893,393
+101,960
| +3% | +$540K | ﹤0.01% | 3309 |
|
|
2021
Q4 | $48.8M | Buy |
3,791,433
+617,115
| +19% | +$6.83M | ﹤0.01% | 2680 |
|
|
2021
Q3 | $34.3M | Buy |
3,174,318
+319,450
| +11% | +$2.91M | ﹤0.01% | 2910 |
|
|
2021
Q2 | $26.1M | Buy |
2,854,868
+458,092
| +19% | +$4.24M | ﹤0.01% | 3138 |
|
|
2021
Q1 | $22.6M | Buy |
2,396,776
+431,270
| +22% | +$5.94M | ﹤0.01% | 3118 |
|
|
2020
Q4 | $7.75M | Sell |
1,965,506
-473,452
| -19% | -$1.43M | ﹤0.01% | 3504 |
|
|
2020
Q3 | $6.46M | Sell |
2,438,958
-15,916
| -0.6% | -$59.1K | ﹤0.01% | 3465 |
|
|
2020
Q2 | $16.3M | Buy |
2,454,874
+275,194
| +13% | +$1.85M | ﹤0.01% | 2909 |
|
|
2020
Q1 | $12.7M | Buy |
2,179,680
+176,999
| +9% | +$1.49M | ﹤0.01% | 2865 |
|
|
2019
Q4 | $18M | Buy |
2,002,681
+411,154
| +26% | +$3.43M | ﹤0.01% | 2938 |
|
|
2019
Q3 | $13.7M | Buy |
1,591,527
+56,902
| +4% | +$575K | ﹤0.01% | 3024 |
|
|
2019
Q2 | $17.1M | Buy |
1,534,625
+1,112,115
| +263% | +$12.7M | ﹤0.01% | 2934 |
|
|
2019
Q1 | $5.62M | Buy |
422,510
+22,406
| +6% | +$299K | ﹤0.01% | 3366 |
|
|
2018
Q4 | $6.18M | Buy |
+400,104
| New | +$7.63M | ﹤0.01% | 3320 |
|
Other funds holding GRTS
BlackRock's GRTS Position: Q4 2024 in Review
BlackRock sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 870,271 shares — an estimated $505K sold.
BlackRock first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $48.8M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- BlackRock reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- BlackRock sold 870,271 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $505K.
- BlackRock first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
- BlackRock's Gritstone bio, Inc. Common Stock position peaked at $48.8M in Q4 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.